The U.S. Senate has a plan to improve drug development for rare disease patients. The exit of controversial CBER chief Vinay Prasad will help clear the path.
Leaders from independent agencies discuss the implications of undermining for-cause protections for regulatory officials.
Multi-member independent agencies have been part of the U.S. government since its earliest days. For centuries, the U.S.
On 20 January 2026, Ropes & Gray’s Global Life Sciences Regulatory & Compliance team hosted the “Life Sciences Regulatory Outlook 2026” webinar. The session provided actionable insights into the most ...
This week, President Donald J. Trump announced the single largest deregulatory action in American history: the full revocation of the disastrous Obama-era “Endangerment Finding” and the consumer ...
Idowu stressed that the agency’s role is not primarily punitive but focused on education and guidance to help practitioners operate within approved standards.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results